A Mouse Model with Features of Familial Combined Hyperlipidemia
- 17 January 1997
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 275 (5298), 391-394
- https://doi.org/10.1126/science.275.5298.391
Abstract
Familial combined hyperlipidemia (FCHL) is a common inherited lipid disorder, affecting 1 to 2 percent of the population in Westernized societies. Individuals with FCHL have large quantities of very low density lipoprotein (VLDL) and low density lipoprotein (LDL) and develop premature coronary heart disease. A mouse model displaying some of the features of FCHL was created by crossing mice carrying the human apolipoprotein C-III (APOC3) transgene with mice deficient in the LDL receptor. A synergistic interaction between the apolipoprotein C-III and the LDL receptor defects produced large quantities of VLDL and LDL and enhanced the development of atherosclerosis. This mouse model may provide clues to the origin of human FCHL.Keywords
This publication has 27 references indexed in Scilit:
- Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.Journal of Clinical Investigation, 1996
- Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.Journal of Clinical Investigation, 1995
- Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene.Journal of Clinical Investigation, 1995
- Association between genetic variation at the APO AI‐CIII‐AIV gene cluster and familial combined hyperlipidaemiaClinical Genetics, 1994
- Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.Journal of Clinical Investigation, 1992
- Familial combined hyperlipidemia and abnormal lipoprotein lipase.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences.Journal of Clinical Investigation, 1992
- Human apolipoprotein A-I--C-III gene complex is located on chromosome 11.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984